Finoriq research workspace
Xtant Medical Holdings, Inc. (XTNT) SEC Filings & Filing Highlights
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for. Review XTNT SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers cervical products comprising Spider cervical plating, Streamline OCT system, and CervAlign systems; thoracolumbar products, such as of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; Silex sacroiliac joint fusion systems; interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; Contact ALP (Anterior Lumbar Plate) System; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. The company is headquartered in Belgrade, Montana.
- Company
- Xtant Medical Holdings, Inc. (XTNT)
- Ticker
- XTNT
- Market Cap
- $61.8M
- Latest Price
- $0.4405
- Industry
- Biotech & Pharma
Xtant Medical Holdings, Inc. (XTNT) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for Xtant Medical Holdings, Inc. (XTNT).
| Event | Form | Date |
|---|---|---|
| Xtant Medical Reports First Quarter 2026 Financial ResultsXtant Medical Reports First Quarter 2026 Financial Results | 8-K8.01 | 2026-05-13 |
| Xtant Medical Reports First Quarter 2026 Financial ResultsXtant Medical Reports First Quarter 2026 Financial Results | 8-K2.02 | 2026-05-13 |
| Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon’s...Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon’s HEMOBLAST® Bellows Product | 8-K8.01 | 2026-04-13 |
| Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon’s...Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon’s HEMOBLAST® Bellows Product | 8-K7.01 | 2026-04-13 |
| Xtant Medical Reports Fourth Quarter and Full-Year 2025 Financial ResultsXtant Medical Reports Fourth Quarter and Full-Year 2025 Financial Results | 8-K2.02 | 2026-03-31 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.